Menu
Back to Journals » Vascular Health and Risk Management » Volume 12
Review
SGLT2 inhibitors or GLP-1 receptor agonists as second-line therapy in type 2 diabetes: patient selection and perspectives
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 35,216 | Dovepress* | 14,204+ | 2,998 | 17,202 | |
| PubMed Central* | 21,012 | 2,471 | 23,483 | ||
| Totals | 35,216 | 5,469 | 40,685 | ||
|
*Since 4 June 2016 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 6 | 2 | 0 | 0 | 1 | 3 |
View citations on PubMed Central and Google Scholar